Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Renal Insufficiency

lopinavir has been researched along with Renal Insufficiency in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bourlon, C; Bourlon, MT; Carretero-Gonzalez, A; Carril-Ajuria, L; Castellano, D; de Velasco, G; Martin-Soberon, M; Remolina-Bonilla, YA1
Aldeguer, JL; Tasias, M1
Burger, DM; de Kanter, CT; Keuter, M; Koopmans, PP; van der Lee, MJ1
Blaszczyk, AT; Vouri, SM1
Caumes, E; Deray, G; Izzedine, H; Launay-Vacher, V; Legrand, M; Lieberherr, D1

Reviews

1 review(s) available for lopinavir and Renal Insufficiency

ArticleYear
[Lopinavir/ritonavir in patients with human immunodeficiency virus infection in special situations].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32 Suppl 3

    Topics: AIDS Dementia Complex; Chemical and Drug Induced Liver Injury; Drug Combinations; Hepatitis, Viral, Human; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; HIV-2; Humans; Lopinavir; Renal Insufficiency; Reverse Transcriptase Inhibitors; Ritonavir; Subarachnoid Space

2014

Other Studies

4 other study(ies) available for lopinavir and Renal Insufficiency

ArticleYear
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
    Oncology (Williston Park, N.Y.), 2020, 08-12, Volume: 34, Issue:8

    Topics: Aged; Androgen Antagonists; Androstenes; Anticoagulants; Antineoplastic Agents; Betacoronavirus; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Coronavirus Infections; COVID-19; Disease Progression; Docetaxel; Drug Combinations; Eligibility Determination; Heparin, Low-Molecular-Weight; Humans; Intensive Care Units; Lopinavir; Male; Oxygen Inhalation Therapy; Palliative Care; Pandemics; Pneumonia, Viral; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Severity of Illness Index; Zoledronic Acid

2020
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.
    Antiviral therapy, 2011, Volume: 16, Issue:3

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Dyslipidemias; Fluorobenzenes; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lopinavir; Male; Middle Aged; Pyrimidines; Pyrimidinones; Renal Insufficiency; Rhabdomyolysis; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2011
HIV: a growing concern in the elderly population.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2012, Volume: 27, Issue:5

    Topics: Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antihypertensive Agents; Azithromycin; CD4 Lymphocyte Count; Depressive Disorder; Diltiazem; Drug Interactions; Drug Monitoring; HIV Infections; Humans; Hypertension; Lopinavir; Male; Patient Compliance; Pharmacists; Renal Insufficiency; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine

2012
ABT 378/r: a novel inhibitor of HIV-1 protease in haemodialysis.
    AIDS (London, England), 2001, Mar-30, Volume: 15, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Leishmaniasis; Lopinavir; Male; Pyrimidinones; Renal Dialysis; Renal Insufficiency; Ritonavir

2001